← Back to Search

Dynamic Contrast-Enhanced MRI for Eye Cancer

N/A

Waitlist Available

Led By Michael Knopp

Research Sponsored by University of Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will help researchers learn more about how best to use a new MRI technique to evaluate diseases of the eye and eye socket.

Who is the study for?

This trial is for individuals who need further diagnosis or monitoring of an orbital mass (eye or eye socket tumor) and can return for follow-up visits. They must be able to give informed consent. It's not suitable for those with severe kidney issues, certain metal implants, allergies to metals or contrast agents, claustrophobia, pregnant women, prisoners, or anyone under conditions that would interfere with MRI.Check my eligibility

What is being tested?

The study tests a new imaging method using dynamic contrast-enhanced MRI to improve the evaluation of diseases in the eye and orbit. It aims to provide detailed images and information about blood circulation in these areas which may help determine if the tumor could spread.See study design

What are the potential side effects?

While this study involves imaging rather than medication, there are still risks associated with MRI scans such as discomfort from lying still during the procedure. There's also a small risk of allergic reaction to the contrast dye used in dynamic MRIs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Diagnosis of benign vs. malignant lesions using DCE-MRI

Improved characterization of different malignant tumor types

Trial Design

1Treatment groups

Experimental Treatment

Group I: Dynamic contrast-enhanced MRIExperimental Treatment1 Intervention

Patients undergo Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor

427 Previous Clinical Trials

634,282 Total Patients Enrolled

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

290,087 Total Patients Enrolled

Michael KnoppPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

dynamic contrast-enhanced MRI Clinical Trial Eligibility Overview. Trial Name: NCT01653080 — N/A

Eye Cancer Research Study Groups: Dynamic contrast-enhanced MRI

Eye Cancer Clinical Trial 2023: dynamic contrast-enhanced MRI Highlights & Side Effects. Trial Name: NCT01653080 — N/A

dynamic contrast-enhanced MRI 2023 Treatment Timeline for Medical Study. Trial Name: NCT01653080 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants in this medical experiment?

"Affirmative. Clinicaltrials.gov reveals that the research is presently enrolling, with first postings dating back to May 18th 2006 and subsequent edits as recent as November 9th 2022. The study requires 160 individuals from a single medical centre for participation."

Answered by AI

Is this experiment still enrolling new participants?

"Affirmative. According to the records on clinicaltrials.gov, this medical trial is still receiving applications for participation. It was initially posted in May of 2006 and recently updated in November 2022 with a target enrollment of 160 participants at one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Michael V Knopp MD PhD 2006. "MRI in Diagnosing Solid Tumors of the Eye and Orbit". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01653080.

All > Paid Studies Ohio